8-K
Current Report
SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-078622
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading sabs-20240627.htm…